Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-resolution optical functional mapping of the human somatosensory cortex.
Koch SP, Habermehl C, Mehnert J, Schmitz CH, Holtze S, Villringer A, Steinbrink J, Obrig H. Koch SP, et al. Among authors: habermehl c. Front Neuroenergetics. 2010 Jun 14;2:12. doi: 10.3389/fnene.2010.00012. eCollection 2010. Front Neuroenergetics. 2010. PMID: 20616883 Free PMC article.
Towards whole-body fluorescence imaging in humans.
Piper SK, Habermehl C, Schmitz CH, Kuebler WM, Obrig H, Steinbrink J, Mehnert J. Piper SK, et al. Among authors: habermehl c. PLoS One. 2013 Dec 31;8(12):e83749. doi: 10.1371/journal.pone.0083749. eCollection 2013. PLoS One. 2013. PMID: 24391820 Free PMC article.
A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors.
Carducci MA, Wang D, Habermehl C, Bödding M, Rohdich F, Lignet F, Duecker K, Karpenko O, Pudelko L, Gimmi C, LoRusso P. Carducci MA, et al. Among authors: habermehl c. Cancer Res Commun. 2023 Aug 24;3(8):1638-1647. doi: 10.1158/2767-9764.CRC-23-0048. eCollection 2023 Aug. Cancer Res Commun. 2023. PMID: 37637935 Free PMC article. Clinical Trial.
Designing phase I oncology dose escalation using dose-exposure-toxicity models as a complementary approach to model-based dose-toxicity models.
Pantoja K, Lanke S, Munafo A, Victor A, Habermehl C, Schueler A, Venkatakrishnan K, Girard P, Goteti K. Pantoja K, et al. Among authors: habermehl c. CPT Pharmacometrics Syst Pharmacol. 2022 Oct;11(10):1371-1381. doi: 10.1002/psp4.12851. Epub 2022 Aug 5. CPT Pharmacometrics Syst Pharmacol. 2022. PMID: 35852048 Free PMC article.
15 results